MedicaidPrior AuthMedium impact
Empliciti (elotuzumab) (New)
Humana·IN · Oncology, Hematology·Medicaid
Effective date
Oct 1, 2025
We identified it
Jun 24, 2026
Summary
Humana Medicaid Indiana has established a new prior authorization policy for Empliciti (elotuzumab), a monoclonal antibody used to treat multiple myeloma. The policy requires prior authorization for all Empliciti prescriptions with specific criteria including diagnosis confirmation, treatment history, and combination therapy requirements.
Action Required
Before October 1, 2025: Billing team must implement prior authorization requirements for Empliciti (elotuzumab) prescriptions for Indiana Medicaid patients. Update billing system to flag these prescriptions and create workflow to verify patient meets criteria: multiple myeloma diagnosis, appropriate prior therapy history, and specific combination therapy protocols. Failure to obtain prior authorization will result in claim denials.